Testing effectiveness (Phase 2)Study completedNCT03227224
What this trial is testing
Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 287